NeuroMetrix, Inc. (NURO) SEC filings
NURO SEC filings moved a median of -0.13% by the close. NURO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NURO overview →
34 measured NURO SEC filing events.
Where these NURO SEC filings landedvs 29 measured NURO SEC filing reactions
| Middle 50% of NURO SEC filing reactions | -5.03% to +1.43% |
|---|---|
| Median reaction (to close) | -0.13% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 NURO SEC filing events with a measured close landed between -5.03% and +1.43%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G NeuroMetrix, Inc. | SEC filing · Form 15-12G | — | — | |
| Form EFFECT NeuroMetrix, Inc. | SEC filing · Form EFFECT | — | — | |
| Form 8-K NeuroMetrix, Inc. For: May 01 | SEC filing · Form 8-K | — | — | |
| Form POS AM NeuroMetrix, Inc. | SEC filing · Form POS | — | — | |
| Form S-8 POS NeuroMetrix, Inc. | SEC filing · Form S-8 | — | — | |
| Form 10-K/A NeuroMetrix, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +7.51% | |
| Form 10-K NeuroMetrix, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +0.48% | |
| Form 8-K NeuroMetrix, Inc. For: Mar 21 | SEC filing · Form 8-K | — | +0.23% | |
| Form DEFM14A NeuroMetrix, Inc. | SEC filing · Form DEFM14A | +0.00% | -0.13% | |
| Form PREM14A NeuroMetrix, Inc. For: Jan 30 | SEC filing · Form PREM14A | +0.00% | +1.41% | |
| Form 8-K NeuroMetrix, Inc. For: Jan 16 | SEC filing · Form 8-K | +0.00% | +4.21% | |
| Form 8-K NeuroMetrix, Inc. For: Dec 27 | SEC filing · Form 8-K | -1.02% | +1.28% | |
| Form 8-K NeuroMetrix, Inc. For: Dec 17 | SEC filing · Form 8-K | -1.71% | -6.11% | |
| Form DEFA14A NeuroMetrix, Inc. | SEC filing · Form DEFA14A | -1.71% | -6.11% | |
| Form 10-Q NeuroMetrix, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.84% | |
| Form 8-K NeuroMetrix, Inc. For: Nov 05 | SEC filing · Form 8-K | +0.97% | -9.21% | |
| Form 10-Q NeuroMetrix, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -8.61% | |
| Form 8-K NeuroMetrix, Inc. For: Aug 06 | SEC filing · Form 8-K | +0.00% | -2.77% | |
| Form SD NeuroMetrix, Inc. | SEC filing · Form SD | — | -0.52% | |
| Form 10-Q NeuroMetrix, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | -1.87% | |
| Form S-8 NeuroMetrix, Inc. | SEC filing · Form S-8 | — | -1.87% | |
| Form 8-K NeuroMetrix, Inc. For: Apr 30 | SEC filing · Form 8-K | — | +5.44% | |
| Form 8-K NeuroMetrix, Inc. For: Apr 18 | SEC filing · Form 8-K | +4.59% | +10.46% | |
| Form DEFA14A NeuroMetrix, Inc. | SEC filing · Form DEFA14A | — | -5.63% | |
| Form 8-K NeuroMetrix, Inc. For: Apr 04 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form DEF 14A NeuroMetrix, Inc. For: Mar 27 | SEC filing · Form DEF | +0.00% | +1.43% | |
| Form 10-K NeuroMetrix, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.75% | -5.03% | |
| Form 8-K NeuroMetrix, Inc. For: Feb 20 | SEC filing · Form 8-K | +0.00% | +3.94% | |
| Form 8-K/A NeuroMetrix, Inc. For: Feb 20 | SEC filing · Form 8-K | +2.29% | +8.65% | |
| Form 8-K NeuroMetrix, Inc. For: Feb 22 | SEC filing · Form 8-K | -0.64% | -6.67% | |
| Form 8-K NeuroMetrix, Inc. For: Nov 20 | SEC filing · Form 8-K | — | +5.15% | |
| Form 10-Q NeuroMetrix, Inc. For: Sep 30 | SEC filing · Form 10-Q | +7.37% | -2.80% | |
| Form 8-K NeuroMetrix, Inc. For: Oct 26 | SEC filing · Form 8-K | -5.42% | -13.86% | |
| Form 8-K NeuroMetrix, Inc. For: Oct 19 | SEC filing · Form 8-K | — | -2.48% |
Keep exploring
More NURO: earnings → · analyst actions → · NURO overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ImmuCell Corporation (ICCC) | 159 | 0.00% | 42% |
| CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN) | 158 | -1.25% | 25% |
| Leap Therapeutics, Inc. (LPTX) | 156 | -0.69% | 43% |
| GOLD FINDER RES LTD (GLDFF) | 155 | +0.19% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.